Skip to main content
Clinical Trials/JPRN-UMIN000012150
JPRN-UMIN000012150
Recruiting
未知

Trial for the initiation of dialysis patients by EPA for prevention of cardiovascular event in Juntendo University Hospital - J-TRIDENT

Department of Internal Medicine,Juntendo University Faculty of Medicine0 sites200 target enrollmentOctober 31, 2013

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Department of Internal Medicine,Juntendo University Faculty of Medicine
Enrollment
200
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 31, 2013
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional,observational
Sex
All

Investigators

Sponsor
Department of Internal Medicine,Juntendo University Faculty of Medicine

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • patient with known bleeding disorders

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
The IDEAL Study: a clinical trial of the timing of kidney dialysis initiation on survival in subjects with chronic kidney disease.Chronic Kidney diseaseCardiac diseaseNutritionRenal and Urogenital - Kidney disease
ACTRN12609000266268Steering Committee of the IDEAL Study800
Completed
Not Applicable
Exploratory clinical trial of dialysis dose monitor with optical measurementEnd stage renal disease
JPRN-UMIN000011082Tokyo Women's Medical University Department of Blood Purification30
Active, not recruiting
Not Applicable
A Study in Renal Predialysis and Dialysis Patients of the Safety, Tolerability, and Immunogenicity of Recombinant Hepatitis B Vaccine Manufactured With a Modified Process - NDProphylactic vaccination against infection with hepatitis B virus in renal predialysis and dialysis patientsMedDRA version: 9.1Level: LLTClassification code 10038474Term: Renal insufficiency
EUCTR2006-003650-20-ITMerck and Co Inc.276
Active, not recruiting
Phase 1
A Study in Renal Predialysis and Dialysis Patients of the Safety,Tolerability, and Immunogenicity of Recombinant Hepatitis BVaccine Manufactured with a Modified Process - Hepatitis B Vaccine (Recombinant) Dialysis StudyHepatitis BMedDRA version: 8.1Level: LLTClassification code 10019731Term: Hepatitis B
EUCTR2006-003650-20-GBMerck & Co Inc.,276
Completed
Not Applicable
The Effects of Dialysis dose at the Initiation of Treatment on Peritoneal Dialysis
JPRN-UMIN000018433Department of Internal Medicine, St. Marianna University School of Medicine, Division of Nephrology and Hypertension80